Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-11-18 Purchase |
2024-11-18 4:20 pm |
Verona Pharma plc | VRNA | EBSWORTH DAVID R Director |
20,000 | $4.44 | $88,800 | 940,003 (Direct) |
View |
| 2024-11-11 Sale |
2024-11-13 4:58 pm |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
2,400 | $5 | $12,000 | 15,202,352 (Direct) |
View |
| 2024-11-11 Sale |
2024-11-13 4:57 pm |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
2,400 | $5 | $12,000 | 14,291,336 (Direct) |
View |
| 2024-11-06 Purchase |
2024-11-07 6:57 pm |
Verona Pharma plc | VRNA | EBSWORTH DAVID R Director |
39,360 | $4.7988 | $188,881 | 920,003 (Direct) |
View |
| 2024-11-06 Purchase |
2024-11-07 6:56 pm |
Verona Pharma plc | VRNA | ACKERMANN CHRISTINA Director |
41,880 | $4.737 | $198,386 | 41,880 (Direct) |
View |
| 2024-11-01 Sale |
2024-11-05 5:41 pm |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
141,032 | $4.3866 | $618,658 | 15,204,752 (Direct) |
View |
| 2024-11-01 Sale |
2024-11-05 5:40 pm |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
129,672 | $4.3833 | $568,387 | 14,293,736 (Direct) |
View |
| 2024-10-24 Sale |
2024-10-25 7:55 pm |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
144,560 | $4.3772 | $632,761 | 13,669,360 (Direct) |
View |
| 2024-10-23 Sale |
2024-10-25 7:54 pm |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
144,816 | $4.3773 | $633,896 | 14,591,736 (Direct) |
View |
| 2024-10-18 Sale |
2024-10-22 8:46 pm |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
514,152 | $4.3824 | $2,253,237 | 14,736,552 (Direct) |
View |
| 2024-10-18 Sale |
2024-10-22 8:45 pm |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
525,768 | $4.3817 | $2,303,773 | 13,813,920 (Direct) |
View |
| 2024-09-11 Sale |
2024-09-13 4:15 pm |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
600,000 | $3.7572 | $2,254,320 | 15,250,704 (Direct) |
View |
| 2024-09-11 Sale |
2024-09-13 4:15 pm |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
600,000 | $3.7568 | $2,254,080 | 14,339,688 (Direct) |
View |
| 2024-08-12 Sale |
2024-08-14 4:16 pm |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
400,000 | $3.2017 | $1,280,689 | 15,850,704 (Direct) |
View |
| 2024-08-12 Sale |
2024-08-14 4:15 pm |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
400,000 | $3.2014 | $1,280,548 | 14,939,688 (Direct) |
View |
| 2024-08-12 Purchase |
2024-08-14 4:15 pm |
Verona Pharma plc | VRNA | EBSWORTH DAVID R Director |
36,000 | $2.87 | $103,320 | 880,643 (Direct) |
View |
| 2024-05-03 Sale |
2024-05-03 7:21 pm |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
36,248 | $1.9596 | $71,032 | 2,621,552 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-10-30 Option Award |
2024-11-01 7:19 pm |
N/A N/A |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
1,000,000 | $0 | 15,345,784 (Direct) |
View |
| 2024-11-01 Tax Withholding |
2024-11-01 7:19 pm |
N/A N/A |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
245,952 | $4.2412 | 15,345,784 (Direct) |
View |
| 2024-10-30 Option Award |
2024-11-01 7:17 pm |
N/A N/A |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
350,000 | $0 | 2,911,480 (Direct) |
View |
| 2024-11-01 Tax Withholding |
2024-11-01 7:17 pm |
N/A N/A |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
65,936 | $4.2412 | 2,911,480 (Direct) |
View |
| 2024-10-30 Option Award |
2024-11-01 7:14 pm |
N/A N/A |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
1,000,000 | $0 | 14,423,408 (Direct) |
View |
| 2024-11-01 Tax Withholding |
2024-11-01 7:14 pm |
N/A N/A |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
245,952 | $4.2412 | 14,423,408 (Direct) |
View |
| 2024-10-30 Option Award |
2024-11-01 7:13 pm |
N/A N/A |
Verona Pharma plc | VRNA | Fisher Andrew General Counsel |
300,000 | $0 | 300,000 (Direct) |
View |
| 2024-08-07 Option Award |
2024-08-09 7:13 pm |
N/A N/A |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
800,000 | $0 | 16,250,704 (Direct) |
View |
| 2024-08-07 Tax Withholding |
2024-08-09 7:13 pm |
N/A N/A |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
314,800 | $2.62 | 16,250,704 (Direct) |
View |
| 2024-08-07 Option Award |
2024-08-09 7:12 pm |
N/A N/A |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
200,000 | $0 | 2,627,416 (Direct) |
View |
| 2024-08-07 Tax Withholding |
2024-08-09 7:12 pm |
N/A N/A |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
87,904 | $2.62 | 2,627,416 (Direct) |
View |
| 2024-08-07 Option Award |
2024-08-09 7:11 pm |
N/A N/A |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
800,000 | $0 | 15,339,688 (Direct) |
View |
| 2024-08-07 Tax Withholding |
2024-08-09 7:11 pm |
N/A N/A |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
314,800 | $2.62 | 15,339,688 (Direct) |
View |
| 2024-08-01 Tax Withholding |
2024-08-05 9:30 pm |
N/A N/A |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
88,544 | $2.8325 | 14,854,488 (Direct) |
View |
| 2024-08-01 Tax Withholding |
2024-08-05 9:29 pm |
N/A N/A |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
88,544 | $2.8325 | 15,765,504 (Direct) |
View |
| 2024-08-01 Tax Withholding |
2024-08-05 9:28 pm |
N/A N/A |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
106,232 | $2.8325 | 2,515,320 (Direct) |
View |
| 2024-05-01 Tax Withholding |
2024-05-03 7:23 pm |
N/A N/A |
Verona Pharma plc | VRNA | Hahn Mark W Chief Financial Officer |
88,544 | $1.9313 | 14,943,032 (Direct) |
View |
| 2024-05-01 Tax Withholding |
2024-05-03 7:21 pm |
N/A N/A |
Verona Pharma plc | VRNA | Rickard Kathleen A. Chief Medical Officer |
73,824 | $1.9313 | 2,621,552 (Direct) |
View |
| 2024-05-01 Tax Withholding |
2024-05-03 7:19 pm |
N/A N/A |
Verona Pharma plc | VRNA | ZACCARDELLI DAVID President and CEO |
88,544 | $1.9313 | 15,854,048 (Direct) |
View |
| 2024-04-29 Option Award |
2024-04-30 4:18 pm |
N/A 2034-04-28 |
Verona Pharma plc | VRNA | Sinha Vikas Director |
240,000 | $0 | 240,000 (Direct) |
View |
| 2024-04-29 Option Award |
2024-04-30 4:17 pm |
N/A 2034-04-28 |
Verona Pharma plc | VRNA | Edwards Martin Director |
240,000 | $0 | 240,000 (Direct) |
View |
| 2024-04-29 Option Award |
2024-04-30 4:17 pm |
N/A 2034-04-28 |
Verona Pharma plc | VRNA | Ullman Anders Director |
240,000 | $0 | 240,000 (Direct) |
View |
| 2024-04-29 Option Award |
2024-04-30 4:17 pm |
N/A 2034-04-28 |
Verona Pharma plc | VRNA | EBSWORTH DAVID R Director |
240,000 | $0 | 240,000 (Direct) |
View |
| 2024-04-29 Option Award |
2024-04-30 4:17 pm |
N/A 2034-04-28 |
Verona Pharma plc | VRNA | ACKERMANN CHRISTINA Director |
240,000 | $0 | 240,000 (Direct) |
View |
| 2024-04-29 Option Award |
2024-04-30 4:17 pm |
N/A 2034-04-28 |
Verona Pharma plc | VRNA | SHAH MAHENDRA Director |
240,000 | $0 | 240,000 (Direct) |
View |
| 2024-04-29 Option Award |
2024-04-30 4:16 pm |
N/A 2034-04-28 |
Verona Pharma plc | VRNA | Cunningham Kenneth Director |
240,000 | $0 | 240,000 (Direct) |
View |
| 2024-04-29 Option Award |
2024-04-30 4:15 pm |
N/A 2034-04-28 |
Verona Pharma plc | VRNA | Brady James Aloysius Director |
240,000 | $0 | 240,000 (Direct) |
View |
| 2024-04-29 Option Award |
2024-04-30 4:15 pm |
N/A 2034-04-28 |
Verona Pharma plc | VRNA | Deschamps Lisa Director |
240,000 | $0 | 240,000 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-02 4:15 pm |
N/A 2034-03-31 |
Verona Pharma plc | VRNA | Fisher Andrew General Counsel |
2,400,000 | $0 | 2,400,000 (Direct) |
View |